tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Viking Therapeutics: A Promising Buy with Strategic Opportunities in Obesity Treatment and Direct-to-Consumer Market
PremiumRatingsViking Therapeutics: A Promising Buy with Strategic Opportunities in Obesity Treatment and Direct-to-Consumer Market
7d ago
Viking Therapeutics Stock Soars Amid Clinical Progress
Premium
Weekend Updates
Viking Therapeutics Stock Soars Amid Clinical Progress
13d ago
Viking Therapeutics Receives Buy Rating Amid Promising Clinical Developments and Strategic Initiatives
Premium
Ratings
Viking Therapeutics Receives Buy Rating Amid Promising Clinical Developments and Strategic Initiatives
14d ago
Viking Therapeutics reports Q2 EPS (58c), consensus (44c)
PremiumThe FlyViking Therapeutics reports Q2 EPS (58c), consensus (44c)
16d ago
Viking Therapeutics options imply 10.2% move in share price post-earnings
Premium
The Fly
Viking Therapeutics options imply 10.2% move in share price post-earnings
16d ago
Options Volatility and Implied Earnings Moves This Week, July 21 – July 24, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, July 21 – July 24, 2025
18d ago
Viking Therapeutics: Buy Rating Affirmed on Promising VK2735 Trials and Strategic Developments
PremiumRatingsViking Therapeutics: Buy Rating Affirmed on Promising VK2735 Trials and Strategic Developments
1M ago
Viking Therapeutics initiates Vanquish Phase 3 clinical program for VK2735
Premium
The Fly
Viking Therapeutics initiates Vanquish Phase 3 clinical program for VK2735
1M ago
Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200%
Premium
Market News
Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200%
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100